Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.
Ichiyasu H, Horio Y, Masunaga A, Migiyama Y, Sakamoto Y, Jodai T, Ideguchi H, Okabayashi H, Hamada S, Yoshida C, Hirosako S, Okamoto S, Kohrogi H. Ichiyasu H, et al. Among authors: hamada s. Ther Adv Respir Dis. 2017 Jul;11(7):261-275. doi: 10.1177/1753465817708950. Epub 2017 May 30. Ther Adv Respir Dis. 2017. PMID: 28554260 Free PMC article. Review.
Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias.
Okabayashi H, Ichiyasu H, Hirooka S, Akaike K, Kojima K, Jodai T, Sakamoto Y, Ideguchi H, Hamada S, Yoshida C, Hirosako S, Okamoto S, Kohrogi H. Okabayashi H, et al. Among authors: hamada s. BMC Pulm Med. 2017 Oct 24;17(1):134. doi: 10.1186/s12890-017-0479-2. BMC Pulm Med. 2017. PMID: 29065861 Free PMC article.
Respiratory evaluation of the risk for postoperative pulmonary complications in patients who preoperatively consulted pulmonologists: Studying both patients who underwent and who precluded planned surgery.
Hirosako S, Nakamura K, Hamada S, Sugahara K, Yoshida C, Saeki S, Kojima K, Okamoto S, Ichiyasu H, Fujii K, Kohrogi H. Hirosako S, et al. Among authors: hamada s. Respir Investig. 2018 Nov;56(6):448-456. doi: 10.1016/j.resinv.2018.07.005. Epub 2018 Aug 23. Respir Investig. 2018. PMID: 30146353
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S, Ichiyasu H, Ikeda T, Inaba M, Kashiwabara K, Sadamatsu T, Sato N, Akaike K, Okabayashi H, Saruwatari K, Tomita Y, Saeki S, Hirata N, Yoshinaga T, Fujii K. Hamada S, et al. BMC Pulm Med. 2019 Apr 2;19(1):72. doi: 10.1186/s12890-019-0838-2. BMC Pulm Med. 2019. PMID: 30940113 Free PMC article.
Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.
Akaike K, Saruwatari K, Oda S, Shiraishi S, Takahashi H, Hamada S, Iyama S, Horio Y, Tomita Y, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Sakagami T. Akaike K, et al. Among authors: hamada s. Int J Clin Oncol. 2020 Apr;25(4):681-690. doi: 10.1007/s10147-019-01584-x. Epub 2019 Nov 28. Int J Clin Oncol. 2020. PMID: 31781994
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment.
Nakashima K, Saruwatari K, Sato R, Imamura K, Kajihara I, Fukushima S, Saito T, Ishizuka S, Tamanoi D, Jodai T, Hamada S, Tomita Y, Saeki S, Ichiyasu H, Oya N, Ihn H, Sakagami T. Nakashima K, et al. Among authors: hamada s. Intern Med. 2020 May 1;59(9):1199-1202. doi: 10.2169/internalmedicine.3937-19. Epub 2020 Feb 12. Intern Med. 2020. PMID: 32051381 Free PMC article.
1,924 results